Friday, November 15, 2024
HomeTagsRenexxion

Renexxion

Renexxion Ireland Announces Issuance of a New US Patent covering Naronapride, a Clinical Stage Potential Best-in-Class Prokinetic Agent for Gastrointestinal disorders

Renexxion Ireland Ltd., a private biopharmaceutical company committed to delivering innovative drugs to patients with high unmet need gastrointestinal ("GI") disorders, announced the issuance...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics